Wellington Management Group LLP Chemo Centryx, Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	SELL	$22.17 - $51.8 $7.36 Million - $17.2 Million	-332,107 Reduced 57.16%	248,943 $12.9 Million
Q2 2022 Aug 15, 2022	SELL	$15.36 - $27.51 $995,066 - $1.78 Million	-64,783 Reduced 10.03%	581,050 $14.4 Million
Q1 2022 May 16, 2022	BUY	$22.22 - $39.12 $3.51 Million - $6.18 Million	157,924 Added 32.37%	645,833 $16.2 Million
Q4 2021 Feb 11, 2022	BUY	$18.38 - $40.5 $8.97 Million - $19.8 Million	487,909 New	487,909 $17.8 Million
Q2 2021 Aug 16, 2021	SELL	$9.59 - $50.88 $58.6 Million - $311 Million	-6,111,277 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$49.53 - $68.4 $1.85 Million - $2.56 Million	-37,402 Reduced 0.61%	6,111,277 $313 Million
Q4 2020 Feb 12, 2021	SELL	$47.25 - $65.16 $26.2 Million - $36.1 Million	-554,655 Reduced 8.27%	6,148,679 $381 Million
Q3 2020 Nov 16, 2020	BUY	$46.35 - $61.69 $88.4 Million - $118 Million	1,906,163 Added 39.74%	6,703,334 $367 Million
Q2 2020 Aug 14, 2020	BUY	$38.58 - $65.07 $185 Million - $312 Million	4,797,171 New	4,797,171 $276 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.